Eur Rev Med Pharmacol Sci 2020; 24 (16): 8250-8250
DOI: 10.26355/eurrev_202008_22591

LncRNA FEZF1-AS1 promoted chemoresistance, autophagy and epithelial-mesenchymal transition (EMT) through regulation of miR-25-3p/ITGB8 axis in prostate cancer

Z.-H. Wang, J.-H. Wang, K.-Q. Wang, Y. Zhou, J. Wang

Department of Urology, West China Hospital, Sichuan University, Chengdu, China.


The article “LncRNA FEZF1-AS1 promoted chemoresistance, autophagy and epithelial-mesenchymal transition (EMT) through regulation of miR-25-3p/ITGB8 axis in prostate cancer, by Z.-H. Wang, J.-H. Wang, K.-Q. Wang, Y. Zhou, J. Wang, published in Eur Rev Med Pharmacol Sci 2020; 24(5): 2281-2293–DOI: 10.26355/eurrev_202003_20494–PMID: 32196579” has been withdrawn from the authors.

 

The Publisher apologizes for any inconvenience this may cause.

LncRNA FEZF1-AS1 promoted chemoresistance, autophagy and epithelial-mesenchymal transition (EMT) through regulation of miR-25-3p/ITGB8 axis in prostate cancer

Free PDF Download

To cite this article

Z.-H. Wang, J.-H. Wang, K.-Q. Wang, Y. Zhou, J. Wang
LncRNA FEZF1-AS1 promoted chemoresistance, autophagy and epithelial-mesenchymal transition (EMT) through regulation of miR-25-3p/ITGB8 axis in prostate cancer

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 16
Pages: 8250-8250
DOI: 10.26355/eurrev_202008_22591